ResultsPatient characteristics58 pairs were matched successfully, one 27-year old patienttreated with gefitinib failed to be matched because of theage. Among the 116 patients, 58 patients with the treat-ment of gefitinib plus CHM and 58 patients with the singledrug treatment of gefitinib (control group). The base-linecharacteristics of patients are given in Table 1.